Trichothecenes: immunomodulatory effects, mechanisms, and anti-cancer potential
Language English Country Germany Media print-electronic
Document type Journal Article, Review
Grant support
31602114
National Natural Science Foundation of China
31572575
National Natural Science Foundation of China
PubMed
29152681
DOI
10.1007/s00204-017-2118-3
PII: 10.1007/s00204-017-2118-3
Knihovny.cz E-resources
- Keywords
- Anti-cancer, Autophagy, Deoxynivalenol, Immune evasion, Immunomodulation, Signaling pathway, T-2 toxin,
- MeSH
- Anticarcinogenic Agents pharmacology MeSH
- Autophagy drug effects immunology MeSH
- Immunoglobulin A immunology MeSH
- Immunologic Factors pharmacology MeSH
- Immunosuppressive Agents pharmacology MeSH
- Infections drug therapy immunology MeSH
- Humans MeSH
- Signal Transduction drug effects immunology MeSH
- Trichothecenes chemistry pharmacology MeSH
- Structure-Activity Relationship MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Anticarcinogenic Agents MeSH
- Immunoglobulin A MeSH
- Immunologic Factors MeSH
- Immunosuppressive Agents MeSH
- Trichothecenes MeSH
Paradoxically, trichothecenes have both immunosuppressive and immunostimulatory effects. The underlying mechanisms have not been fully explored. Early studies show that dose, exposure timing, and the time at which immune function is assessed influence whether trichothecenes act in an immunosuppressive or immunostimulatory fashion. Recent studies suggest that the immunomodulatory function of trichothecenes is also actively shaped by competing cell-survival and death-signaling pathways. Autophagy may also promote trichothecene immunosuppression, although the mechanism may be complicated. Moreover, trichothecenes may generate an "immune evasion" milieu that allows pathogens to escape host and vaccine immune defenses. Some trichothecenes, especially macrocyclic trichothecenes, also potently kill cancer cells. T-2 toxin conjugated with anti-cancer monoclonal antibodies significantly suppresses the growth of thymoma EL-4 cells and colon cancer cells. The type B trichothecene diacetoxyscirpenol specifically inhibits the tumor-promoting factor HIF-1 in cancer cells under hypoxic conditions. Trichothecin markedly inhibits the growth of multiple cancer cells with constitutively activated NF-κB. The type D macrocyclic toxin Verrucarin A is also a promising therapeutic candidate for leukemia, breast cancer, prostate cancer, and pancreatic cancer. The anti-cancer activities of trichothecenes have not been comprehensively summarized. Here, we first summarize the data on the immunomodulatory effects of trichothecenes and discuss recent studies that shed light on the underlying cellular and molecular mechanisms. These mechanisms include autophagy and major signaling pathways and their crosstalk. Second, the anti-cancer potential of trichothecenes and the underlying mechanisms will be discussed. We hope that this review will show how trichothecene bioactivities can be exploited to generate therapies against pathogens and cancer.
References provided by Crossref.org
Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape
Deoxynivalenol Induces Inflammation in IPEC-J2 Cells by Activating P38 Mapk And Erk1/2
A Review on the Synthesis and Bioactivity Aspects of Beauvericin, a Fusarium Mycotoxin